The discovery by Campbell and colleagues that skin-homing cutaneous lymphocyte antigen (CLA)+ T cells express high levels of CCR4 expression (Campbell et al., 1999), implicated the receptor in the pathology of atopic dermatitis. The gene discussed is CCR4; the disease is atopic eczema.